Partly Cloudy

Partly Cloudy

max temp: 8°C

min temp: 7°C


Suffolk: Cancer survivor slams NICE after it claims life-extending drug is ‘too expensive’

12:00 23 April 2014

Cancer survivor Jo Whitelaw

Cancer survivor Jo Whitelaw

A breast cancer survivor has hit out at plans to block a new drug, which extends cancer patients’ lives by almost six months, from NHS access.


Mother-of-two Jo Whitelaw, from Great Blakenham, was diagnosed with HER2-positive breast cancer in February 2012, 
underwent a mastectomy, chemotherapy and Herceptin medication and has just had the two year all-clear.

The 51-year-old has slammed draft guidance from the National Institute for Health and Care Excellence (Nice) stating Kadcyla, which is manufactured by Roche and can cost more than £90,000 per patient, is not effective enough to justify the price the NHS is being asked to pay.

It means if the decision is made final, patients would have to apply to the NHS and the Cancer Drugs Fund for the drug.

Mrs Whitelaw said: “It infuriates me that the big people at the top can go along saying the drug can’t be rolled out on the NHS because it’s too expensive but if someone in their family was diagnosed with breast cancer they would soon change their mind.

“You can’t put a price on life. For somebody to say your life is not worth the cost of the drug is absolutely disgraceful.

“I can’t imagine what breast cancer patients are going through and words can’t describe how angry I feel on their behalf.

“I have seen people sitting in the waiting room and the anxiety on their faces is beyond words.”

Professor Paul Ellis, a consultant oncologist at King’s College, and lead triallist for the drug in the UK, said: “Kadcyla represents a significant advance in HER2-positive breast cancer, so for Nice to issue negative preliminary guidance is a huge blow.

“The drug tackles the disease in a different way to any other breast cancer medicine and provides women with valuable extra time with their families and loved ones – time that you cannot put a price on.”

The drug is currently given to patients who have failed on conventional treatment with Herceptin and chemotherapy.

It is only suitable for patients with the defective Her2 gene and trial results have showed it can extend life by six months.

Sir Andrew Dillon, Nice chief executive, said: “We had hoped Roche would have recognised the challenge the NHS faces in managing the adoption of expensive new treatments by reducing the cost of Kadcyla to the NHS.

“The drug is already being funded through the special Cancer Drugs Fund. Our job is to recommend whether it should transfer into the NHS budget.

“We are very aware of the importance that people place on life-extending cancer drugs and a decision not to recommend a cancer treatment for routine NHS funding is never taken lightly.”

Jayson Dallas, general manager, Roche Products Limited, said: “Roche is extremely disappointed that Nice has failed to safeguard the interests of patients with this advanced stage of aggressive disease.”

A spokesman added Roche would be working with Nice as part of the consultation period before a final decision is made.



  • This is why your Government needs major stakes in the worlds pharmaceutical companies rather than the banks... but then again, financial crimes always have a longer custodial sentence than crimes committed against the person. Money still seems more important than lives. You can understand why people are angry at them refusing to stock the drug on cost grounds - bare in mind its not £90k per person, or nothing - those with HER2 would be given an alternative combination of medicine that I would expect to cost over half of that.... the difference is this more expensive drug is more effective and can extend lives by up to 6 months... oh and then there is the useless stockpile the Government blown taxpayers money on that wouldn't have helped against an epidemic... I am sure that would have made up the shortfall between medicine costs.

    Report this comment

    Ipswich Entrepreneur

    Wednesday, April 23, 2014

  • Unfortunate that some people don't understand the concept of NICE looking at affordability. If it improved quality of life substantially enough then £90k year-1 would probably be okay. It's guidance is there to protect the patients so that they are not sold promises at a high price which will not deliver. It's there to make companies such as Roche rethink their pricing so that they can sell their product to the NHS, otherwise a drugs company could just charge whatever

    Report this comment

    daniel ......

    Wednesday, April 23, 2014

  • We do have a lot of money in the NHS pot but a lot of it is going to people who have never contributed to the system and those from abroad who are milking it.

    Report this comment


    Wednesday, April 23, 2014

  • I'm sure anyone in this position would want to take any option available. But this country cannot afford to spend this amount of money to delay the inevitable by 6 months. If it was a cure then that would be completely different. How many hip replacements, dialysis machines or A&E nurses would these treaments provide - making long term health benefits to more people.

    Report this comment

    John Felton

    Wednesday, April 23, 2014

  • It's wrong to characterise this as a "life-saving" drug as a lot of the media are doing. All it does is extend life by a short time. While that's undoubtedly a boon for those receiving it, NICE has to make an assessment on the basis of the amount (and quality) of life any particular drug will give, against its cost. If we had an infinite amount of money for the NHS this wouldn't be a problem, but in the real world, unfortunately cost-benefit analyses have to be done. I'm sure if this drug actually *CURED* sufferers' cancers, or even provided a significant extension of good-quality life, the decision would have been different.

    Report this comment


    Wednesday, April 23, 2014

The views expressed in the above comments do not necessarily reflect the views of this site

The fire service cordons off an area near Marks and Spencer in Westgate Street where UK Power Networks works to find a  carbon monoxide leak

Marks and Spencer in Ipswich will reopen at 4pm after being closed for the day due to a carbon monoxide leak.

Stores in Ipswich ready for Black Friday.

Black Friday is nearly upon us and it is set to kick off the busiest Christmas online shopping periods.

Foundation Street, Ipswich, around a century ago. Little remains of the ancient buildings in this street. This photograph was taken from near the junction of Lower Brook Street.

Foundation Street is one of the oldest streets in Ipswich, connecting the port with the town centre. Buildings which had stood for centuries were demolished in the early 1960s in what was then seen as “improvements”.

Hawkedon Veterinary Surgery is sponsoring a bag dispenser and bags for dog walkers to pick up and dispose of dog’s mess in Nowton Park, Bury St Edmunds. Left to right, Cllr Joanna Rayner and veterinary surgeon Rosina Page-Baker with Marley the dog.

A new initiative to reduce dog fouling in west Suffolk has seen dog bag dispensers installed at two popular parks.

Could the Crown car park be replaced by a prefab platform like this one at Manningtree?

Should Ipswich Borough Council spend £3million on doubling the size of the Crown Car Park – or go the whole hog and quadruple it at a cost of about £12m?

On going work at Ipswich Station

Work on a near-£2million refurbishment of Ipswich railway station has started – and is set to continue until August next year.

Police at the scene of the alleged robbery

A 25-year-old man from south London who was arrested following a robbery at a convenience store in Claydon has been charged.

Artist's impression of the homes there were proposed for lane close to Poplar Lane, Sproughton.

Babergh district councillors last night said they had voted against officers’ advice and refused a 475-home development on the edge of Ipswich because its design was “appalling”.

Annual Bury St Edmunds Christmas Fayre

The annual Christmas Fayre will see around 120,000 people descend on Bury St Edmunds over four days.

Nick Alexander, who died in the Bataclan massacre, in Paris, France. Photo: Foreign & Commonwealth Office/PA Wire.

The singer from the Eagles of Death Metal has paid tribute to Nick Alexander for his selflessness during the massacre at the Paris theatre where 89 people died almost two weeks ago.

Most read

Most commented

Topic pages

Local business directory

Suffolk's trusted business finder

Property search

e.g. Oxford or NW3
Powered by Zoopla

Digital Edition

Read the Ipswich Star e-edition today E-edition

Great British Life

Great British Life
MyDate24 MyPhotos24